The Prof G Pod with Scott Galloway
Prof G Markets: Ozempic’s Market Impacts and Surging Bond Yields — with Downtown Josh Brown
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
This week on Prof G Markets, Scott shares his thoughts on which stocks and sectors could get a boost or take a hit from Ozempic’s increasing popularity. Then, Josh Brown, CEO of Ritholtz Wealth, joins the show to help break down why bond yields have surged the past few weeks.
Learn more about your ad choices. Visit podcastchoices.com/adchoices